Dimethicone Copolyols are chemically and physically inert ingredients used in cosmetics in a concentration range of less than or equal to 0.1-10%. This compound is, at most, slightly toxic to the rat when administered orally or dermally in a single dose. Copolyols were not primary skin or ocular irritants in the rabbit and gave no evidence of subchronic oral toxicity when fed to rats.
Clinical studies showed that these Copolyols are neither primary skin irritants nor sensitizers when tested at a 100% concentration.
On the basis of the available information presented in this report, it is concluded that Dimethicone Copolyol is safe as a cosmetic ingredient in the present practices of use and concentration.
Hobbs, E.J., Keplinger, M.L., and Calandra, J.C.(1975). Toxicity of polydimethylsiloxanes in certain environmental systems. Environ. Res.10(3), 397–406.
3.
Murthy, S.K. and Nathan, S.S.(1962). Organic Chemistry Made Simple.Garden City, NY: Double-day and Co. pp. 248–51.
4.
Hawley, G.G.(ed.). (1971). The Condensed Chemical Dictionary.New York, NY: Van Nostrand Reinhold Co.
5.
COSMETIC, TOILETRY and FRAGRANCE ASSOCIATION (CTFA). (November 9, 1979). Submission of data. Summary of Unpublished Safety Data on Dimethicone Copolyols.
6.
CTFA. (November 9, 1979). Submission of data. Cosmetic Ingredient Chemical Description for Dimethicone Copolyol.
7.
McGregor, R.R. (1954). Silcones and Their Uses.New York, NY: McGraw-Hill Book Co.
8.
Weast, R.C.(ed.). (1976). Handbood of Chemistry and Physics.57th ed.Cleveland, OH: CRC Press.
9.
Hobbs, E.J., Fancher, O.E., and Calandra, J.C.(1972). Effect of selected organopolysiloxanes on male rat and rabbit reproductive organs. Toxicol. Appl. Pharmacol.21(1), 45–54.
10.
Scott, R.J. and Turney, M.E.(1979). Volatile silicones in suspensoid antiperspirant sticks. J. Soc. Cosmet. Chem.30, 137–56.
11.
Windholz, M.(ed.). (1976). The Merck Index, 9th ed.Rahway, NJ: Merck and Co.
12.
Kuwahara, N. (1963). Polymer-solvent interaction in polymer solutions. J. Polym. Sci.A1(7), 2395–406.
13.
Kuwahara, N., Okazawa, T., and Kaneko, M.(1969). Osmotic pressures of moderately concentrated poly-(dimethylsiloxane) solutions. J. Polym. Sci.C23(2), 543–53.
14.
O'Neill, I.K., Pringuer, M.A., and Prosser, H.J. (1975). Comparison of the nuclear magnetic resonance and infrared spectroscopic methods for the quantitative analysis of polydimethylsiloxane. J. Pharm. Pharmacol.27, 222–5.
15.
Anhoury, M.L., Crooy, P., De Neys, R., and Laridant, A. (1976). Rapid determination of dimethylpolysiloxane by proton magnetic resonance spectroscopy. J. Pharm. Sci.65, 590–2.
16.
Kass, G.S. (1965). Solvents to improve compatability of silicones with cosmetic raw materials. U.S. Pat.3,185,627.
17.
Todd, C. and Byers, T.(1976). Volatile silicone fluids for cosmetic formulations. Cosmet. Toiletries91(1), 29–32.
18.
FOOD and DRUG ADMINISTRATION (FDA). (August 31, 1976). Cosmetic product formulation data. Computer Printout.
19.
Cox, H.L.M. and Nijland, C.J.(1976). Antifoaming action of silicone preparations. Pharm. Weekbl.111(40), 973–85.
20.
Birtley, R.D.N., Burton, J.S., Kellett, D.N., Oswald, B.J., and Pennington, J.C.(1973). Effect of free silica on the mucosal protective and antiflatulent properties of polydimethylsiloxane (dimethicone). J. Pharm. Pharmacol.25, 859–63.
21.
Althaus, W., Baronnet, R., Voissier, G., and Wischniewski, M.(1974). Antifoam activity of dimethylpolysiloxanes (dimethicones) for gastroenterology: determination of their effectiveness. Ann. Pharm. Fr.32, 193–201.
22.
FEDERAL REGISTER. (1963). Food additives. Defoaming agents. Fed. Reg.28, 11475–6.
23.
FEDERAL REGISTER. (1965). Food additives. Lubricants with incidental food contact. Fed. Reg.30, 8334.
24.
McNamara, B.P., McKay, E.A., and Quille, M.M.(1959). Silicone fluids as vehicles for the intramuscular administration of drugs. Fed. Proc.9(1), 301.
25.
Pratt, W.D. (1971). Dimethylpolysiloxane vaccine suspensions. U.S. Pat.3,577,524.
26.
Stubblefield, P.G. (1977). Vaginal silastic device containing 0.25 percent 15(S)-15-methylprosta-glandin F2-alpha-methyl ester for early second trimester abortion. Contraception15, 175–81.
27.
Asker, A.F. and Whitworth, C.W.(1974). Evaluation of dimethylpolysiloxane fluids as vehicles for various pharmaceuticals. 1. Effect on stability and dissolution of aspirin. J. Pharm. Sci.63, 1630–1.
28.
Asker, A.F. and Whitworth, C.W.(1976). Effect of dimethylpolysiloxane fluid on the stability and dissolution of prednisolone. Pharmazie31, 240–1.
Gibor, Y. (1971). Diffusion of progesterone through intrauterine silastic rubber implants. Fert. Steril.22(10), 671–6.
31.
Hillier, S.G., Jha, P., Griffiths, K., and Laumas, K.R.(1977). Long-term contraception by steroid releasing implants. 6. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate. Contraception15, 473–88.
32.
Kincl, F.A., Angee, I., Chang, C.C., and Rudel, H.W.(1970). Sustained-release hormonal preparations. IX. Plasma levels and accumulation into various tissues of 6-methyl-17-alpha-acetoxy-4, 6-pregnadiene-3, 20-dione after oral administration or absorption from polydimethylsiloxane implants. Acta. Endocrinol.64(3), 508–18.
33.
Nilsson, C.G. (1977). Comparative quantitation of menstrual blood loss with a d-norgestrel releasing IUD and a Nova-T copper device. Contraception15, 379–87.
34.
Nilsson, C.G. and Lahteenmaki, P.(1977). Recovery of ovarian function after the use of a d-norgestrel releasing IUD. Contraception15, 389–400.
35.
Scommegna, A., Pandya, G.N., Christ, M., Lee, A.W., and Cohen, M.R.(1970). Intrauterine administration of progesterone by a slow releasing device. Fert. Steril.21(3), 201–10.
36.
Tatum, H.J. (1970). Fertility control and acceptability in women of contraceptive steroids released in microquantities from subcutaneous silastic capsules. Contraception1(4), 253–63.
37.
Chang, C.C. and Kincl, F.A.(1970). Sustained-release hormonal preparation. IV. Biologic effectiveness of steroid hormones. Fert. Steril.21(2), 134–9.
38.
Jeyaseelan, S., Takkar, D., Bhuyan, U.N., Laumas, K.R., and Hingorani, V.(1977). Local tissue response to silastic implant containing norethindrone acetate in women. Contraception15, 39–51.
39.
Aronov, E.G., Rapoport, R.M., and Gerner, M.M. (1961). Elastic mass for dental impressions. USSR Pat. 134,819.
40.
Morrow, G. (1954). The use of silicones to protect the skin. Calif. Med.80(1), 21–2.
41.
Levan, P., Sternberg, T.H., and Newcomer, V.D.(1954). The use of silicones in dermatology. Calif. Med.81(3), 210–13.
42.
Dennett, F.A. (1966). Current situation on use of Dow Corning silicone fluid for soft tissue augmentation by injection (dimethylpolysiloxane mammary augmentation, facial hemiatrophy, wrinkle eradication). Arch. Otolaryngol.83(5), 508.
43.
Schuetz, E. (1967). Influence of drugs on the disturbances of carbohydrate digestion. Med. Welt.15, 968–72.
44.
Ballantyne, Jr., D.L., Hawthorne, G.A., Rees, T.D., and Seidman, I. (1971). An experimental evaluation of skin graft preservation with silicone fluid. Cryobiology8(2), 211–15.
45.
Nosanchuk, J.S. (1968). Injected dimethylpolysiloxane fluid: a study of antibody and histologic response. Plast. Reconstr. Surg.42(6), 562–6.
46.
Hine, C.H., Elliott, E.W., Wright, R.R., Cavalli, R.D., and Porter, CD. (1969). Evaluation of a silicone lubricant injected spinally. Toxicol. Appl. Pharmacol.15(3), 566–73.
47.
Carter, Ii, B.N. and Sherman, R.T. (1957). Dimethicone (silicone) skin protection in surgical patients. Arch. Surg. 116-7.
48.
McGregor, R.R. (1960). Toxicology of the Silicones. I. The Bulletin of the Dow-Corning Center for Aid to Medical Research.2(4), 15–6.
49.
Bateman, F.J.A. (1956). Silicone barrier cream in prevention of bed sores. Brit. Med. J. 554.
50.
Suskind, R.R. (1955). The present status of silicone protective creams. Ind. Med. Surg.24, 413–6.
51.
Kennedy, Jr., G.L., Keplinger, MX., Calandra, J.C., and Hobbs, E.J. (1976). Reproductive, teratologic, and mutagenic studies with some polydimethylsiloxanes. J. Toxicol. Environ. Health1(6), 909–20.
52.
CTFA. (1956). Submission of data. Carnegie Mellon Institute Special Report 19-82.
53.
CTFA. (1962). Submission of data. Carnegie Mellon Institute Special Report 25-54.
54.
CTFA. (1963). Submission of data. Carnegie Mellon Institute Special Report 26-122.
55.
CTFA. (1963). Submission of data. Carnegie Mellon Institute Special Report 26-9.
56.
CTFA. (1966). Submission of data. Industrial Bio-Test Report A4420.
57.
CTFA. (1966). Submission of data. Industrial Bio-Test Report A4679.
58.
CTFA. (1976). Submission of data. Carnegie Mellon Institute Special Report 39-16.
59.
CTFA. (1966). Submission of data. Industrial Bio-Test Report A4671-2.
60.
CTFA. (1966). Submission of data. Industrial Bio-Test Report A4357.
61.
CTFA. (June 22, 1972). Submission of data. Clinical Evaluation Report. Profile No. I 4825. Primary Skin Irritation in Humans. Dow Corning EF 1-3574-B-40 percent in H2O.
62.
CTFA. (May 2, 1973). Submission of data. Clinical Evaluation Report. Profile No. 49995. Relative Primary Irritation in Human Skin. Dow Corning 472 Fluid.
CTFA. (1973). Submission of data. Hill Top Research Report 73-375-70.
66.
Rowe, V.K., Spencer, H.C., and Bass, S.L.(1948). Toxicological studies on certain commercial silicones and hydrolyzable silane intermediates. J. Indust. Hyg. and Toxicol.30(6), 332–52.
67.
Hawthorne, G.A., Ballantyne, Jr., D.L., Rees, T.D., and Seidman, I. (1970). Hematological effects of dimethylpolysiloxane fluid in rats. Res. J. Reticuloendothel. Soc.7(5), 587–93.
68.
Ballantyne, Jr., D.L., Hawthorne, G., Ben-Hur, N., Seidman, I., and Rees, T.D. (1971). Effect of silicone fluid on experimentally-induced peritoneal adhesions. Isr. J. Med. Sci.7(9), 1046–9.
69.
Cutler, M.G., Collings, A.J., Kiss, I.S., and Sharratt, M.(1974). A life span study of a poly-dimethylsiloxane in the mouse. Food Cosmet. Toxicol.12(4), 443–50.
70.
Clark, Jr., L.C. and Gollan, F. (1966). Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science152(3730), 1755–6.
71.
McDonald, W.E., Lanier, G.E., and Deichmann, W.B.(1960). Subacute oral toxicity to the rat of certain polydimethylsiloxanes. A.M.A. Arch. Ind. Health21, 514–8.
72.
Johnson, A. (1976). Nonsteroid skin cream in traumatic dermatoses: a clinical open evaluation. Med. J. Aust.1, 111–3.
